Ian King

2.7k total citations
34 papers, 1.8k citations indexed

About

Ian King is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ian King has authored 34 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ian King's work include Neurobiology and Insect Physiology Research (6 papers), Epigenetics and DNA Methylation (6 papers) and Melanoma and MAPK Pathways (5 papers). Ian King is often cited by papers focused on Neurobiology and Insect Physiology Research (6 papers), Epigenetics and DNA Methylation (6 papers) and Melanoma and MAPK Pathways (5 papers). Ian King collaborates with scholars based in United States, Canada and Australia. Ian King's co-authors include Robert E. Kingston, Ulrike Heberlein, Stuart S. Levine, Benjamin D. Philpot, Mark J. Zylka, Nicole J. Francis, Angela M. Mabb, Anita V. Devineni, Ryan Matthew Joseph and Hsien‐Sung Huang and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Neuron.

In The Last Decade

Ian King

29 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian King United States	18	1.2k	594	250	162	153	34	1.8k
Eswar Prasad R. Iyer United States	12	1.4k 1.2×	219 0.4×	230 0.9×	135 0.8×	79 0.5×	19	1.7k
Steven M. Bray United States	14	683 0.6×	899 1.5×	601 2.4×	50 0.3×	75 0.5×	19	1.6k
Julie Secombe United States	18	1.2k 1.0×	210 0.4×	128 0.5×	123 0.8×	98 0.6×	31	1.5k
Tong‐Wey Koh United States	13	1.8k 1.5×	412 0.7×	1.1k 4.2×	78 0.5×	107 0.7×	17	2.6k
Meera V. Sundaram United States	31	1.5k 1.3×	136 0.2×	296 1.2×	147 0.9×	147 1.0×	55	2.9k
Jill R. Crittenden United States	16	560 0.5×	231 0.4×	631 2.5×	76 0.5×	52 0.3×	33	1.5k
Jay P. Uhler Sweden	18	1.1k 0.9×	218 0.4×	507 2.0×	101 0.6×	24 0.2×	23	1.6k
Rory Kirchner United States	21	994 0.8×	253 0.4×	309 1.2×	45 0.3×	40 0.3×	36	1.8k
Jian‐Quan Ni China	23	1.5k 1.2×	273 0.5×	354 1.4×	258 1.6×	50 0.3×	44	1.9k
Clara Benna Italy	18	493 0.4×	161 0.3×	291 1.2×	177 1.1×	96 0.6×	44	1.3k

Countries citing papers authored by Ian King

Since Specialization

Citations

This map shows the geographic impact of Ian King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian King more than expected).

Fields of papers citing papers by Ian King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian King. The network helps show where Ian King may publish in the future.

Co-authorship network of co-authors of Ian King

This figure shows the co-authorship network connecting the top 25 collaborators of Ian King. A scholar is included among the top collaborators of Ian King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian King. Ian King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rose, April A. N., Ian King, Tong Zhang, et al.. (2024). Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Final results of the investigator-initiated phase II BEAVER trial.. Journal of Clinical Oncology. 42(16_suppl). 3104–3104. 2 indexed citations

Danos, Arpad, Laura Corson, Daniel J. Brat, et al.. (2024). 52. A ClinGen Somatic curation effort focused on EGFR variants. Cancer Genetics. 286-287. S17–S17.

King, Ian, Tracy Stockley, Samuel D. Saibil, et al.. (2022). Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer Center. JCO Oncology Practice. 18(5). e642–e647.

Smith, Adam C., Dawn Maze, Daniel Xia, et al.. (2022). A t(6;14;9)(p22;q22;q34) three‐way translocation: Description of a cytogenetically visible variant t(6;9) in acute myeloid leukemia. American Journal of Hematology. 97(7). 983–985. 2 indexed citations

Rose, April A. N., Sofia Genta, Deirdre Kelly, et al.. (2021). 531P Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Preliminary results of the investigator initiated phase II BEAVER trial. Annals of Oncology. 32. S596–S596.

Rose, April A. N., Deirdre Kelly, David Hogg, et al.. (2020). 1144P Clinical predictors of therapeutic benefit from anti-PD1 immune checkpoint inhibitors (ICI) in patients (pts) with metastatic uveal melanoma. Annals of Oncology. 31. S764–S765.

Leigh, Margaret W., Karen E. Weck, Ian King, et al.. (2018). The prevalence of the defining features of primary ciliary dyskinesia within a cri du chat syndrome cohort. Pediatric Pulmonology. 53(11). 1565–1573. 4 indexed citations

Mabb, Angela M., Jeremy M. Simon, Ian King, et al.. (2016). Topoisomerase 1 Regulates Gene Expression in Neurons through Cleavage Complex-Dependent and -Independent Mechanisms. PLoS ONE. 11(5). e0156439–e0156439. 36 indexed citations

Judson, Matthew C., Michael L. Wallace, Michael S. Sidorov, et al.. (2016). GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility. Neuron. 90(1). 56–69. 119 indexed citations

10.

King, Ian, Mark Eddison, Karla R. Kaun, & Ulrike Heberlein. (2014). EGFR and FGFR Pathways Have Distinct Roles in Drosophila Mushroom Body Development and Ethanol-Induced Behavior. PLoS ONE. 9(1). e87714–e87714. 18 indexed citations

11.

King, Ian, Chandri Yandava, Angela M. Mabb, et al.. (2013). Topoisomerases facilitate transcription of long genes linked to autism. Nature. 501(7465). 58–62. 297 indexed citations

12.

Kapfhamer, David, Ian King, Mimi E. Zou, et al.. (2012). JNK Pathway Activation Is Controlled by Tao/TAOK3 to Modulate Ethanol Sensitivity. PLoS ONE. 7(12). e50594–e50594. 31 indexed citations

13.

Huang, Hsien‐Sung, John A. Allen, Angela M. Mabb, et al.. (2011). Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature. 481(7380). 185–189. 287 indexed citations

14.

King, Ian & Ulrike Heberlein. (2011). Tao kinases as coordinators of actin and microtubule dynamics in developing neurons. Communicative & Integrative Biology. 4(5). 554–556. 12 indexed citations

15.

King, Ian, Linus Tsai, Ralf Pflanz, et al.. (2011). Drosophila taoControls Mushroom Body Development and Ethanol-Stimulated Behavior throughpar-1. Journal of Neuroscience. 31(3). 1139–1148. 53 indexed citations

16.

King, Ian, Nicole J. Francis, Brigitte Wild, et al.. (2005). Analysis of a Polycomb Group Protein Defines Regions That Link Repressive Activity on Nucleosomal Templates to In Vivo Function. Molecular and Cellular Biology. 25(15). 6578–6591. 64 indexed citations

17.

Lavigne, Marc, Nicole J. Francis, Ian King, & Robert E. Kingston. (2004). Propagation of Silencing. Molecular Cell. 13(3). 415–425. 78 indexed citations

18.

Mulholland, Niveen, Ian King, & Robert E. Kingston. (2003). Regulation of Polycomb group complexes by the sequence-specific DNA binding proteins Zeste and GAGA. Genes & Development. 17(22). 2741–2746. 56 indexed citations

19.

King, Ian, Nicole J. Francis, & Robert E. Kingston. (2002). Native and Recombinant Polycomb Group Complexes Establish a Selective Block to Template Accessibility To Repress Transcription In Vitro. Molecular and Cellular Biology. 22(22). 7919–7928. 83 indexed citations

20.

Henkler, Frank, et al.. (2001). Trangenic Misexpression of the Differentiation-Specific Desmocollin Isoform 1 in Basal Keratinocytes. Journal of Investigative Dermatology. 116(1). 144–149. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact